To promote understanding and awareness of the teaching practice of narrative medical education in Chinese medical schools, and to accelerate the promotion of standardized practice, research and development in this field

To unify practitioners' understanding and awareness of the practice path of hospital narrative medicine, and to accelerate the standardized practice, research and development of hospital narrative medicine in China.

To unify practitioners' understanding and awareness of the construction of humanistic departments in medical institutions, and accelerate the promotion of standardized practice, research and development of humanistic departments.

As the aging population progresses, spinal compression fractures due to osteoporosis are becoming more common. The segment of the spine most prone to osteoporotic fractures is the thoracolumbar segment. For osteoporotic thoracolumbar compression fractures, the most commonly used clinical treatment is vertebral body strengthening (such as percutaneous vertebroplasty and percutaneous kyphoplasty), which has the advantages of good pain relief and rapid restoration of the patient's mobility, which is in line with the rehabilitation concept of ERAS. However, some patients have vertebral re-fracture after surgery, which seriously affects the patients' quality of life and brings a lot of trouble to spine surgeons. How to prevent and manage vertebral body re-fracture has been the focus of discussion among spine surgeons, and there is a lack of expert consensus and clinical guidelines in this area. Based on the above, led by the Spinal Trauma Academic Group of Orthopedics Branch of Chinese Medical Doctor Association, through a systematic literature review, discussed by the representatives of domestic spine experts, and based on evidence-based medicine, we intend to work together to formulate this guideline. with a view to providing reference for the standardization of vertebral re-fracture prevention and treatment after vertebral body strengthening for osteoporotic thoracolumbar compression fractures, to improve the clinical prognosis of patients, and to save medical costs.

Cancer cachexia is defined as the loss of appetite or anorexia caused by the tumor itself and/or its treatment. Cancer cachexia consists of multiple symptoms, such as anorexia, nausea, taste changes, early satiety, or difficulty swallowing. Studies have shown that over 75% of patients with advanced-stage tumors have symptoms of cancer cachexia, and more than half of cancer patients express concern about anorexia and/or weight loss. Reduced appetite not only affects the nutritional status of patients but is also closely associated with a shortened survival time, reduced compliance with anti-tumor treatment, increased treatment-related side effects, and a decline in quality of life, among other serious adverse events. Currently, cancer cachexia is prevalent but often overlooked in clinical practice, and there is still a lack of sufficient understanding of its pathogenesis. The standards for screening and diagnostic processes have not been unified, and there is no widespread consensus on the timing of intervention and treatment methods. To standardize the diagnosis and treatment process of cancer cachexia to guide clinical and research work, the Support and Rehabilitation Expert Committee (SCRC) of the Chinese Society of Clinical Oncology (CSCO) has invited experts in related fields in China to formulate the "Chinese Expert Consensus on Cancer Cachexia." This consensus will become an important reference for clinical physicians in the diagnosis and treatment of cancer cachexia, better standardize the diagnosis and treatment of cancer cachexia, actively screen, intervene early, and standardize treatment, benefiting more patients.